Consensus guidelines, algorithms and care of the individual patient with type 2 diabetes.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).Diabetes care · 2012 · on this map
   Guideline
2. Effect ofSaudi journal of biological sciences · 2019
   Article
3. Personalizing guidelines for diabetes management: twilight or dawn of the expert?BMC medicine · 2013
   Review
4. Stepwise intensification of insulin therapy in type 2 diabetes management--exploring the concept of the basal-plus approach in clinical practice.Diabetic medicine : a journal of the British Diabetic Association · 2013
   Review
5. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).Diabetologia · 2012 · on this map
   Article
6. Insulin initiation in patients with type 2 diabetes mellitus: treatment guidelines, clinical evidence and patterns of use of basal vs premixed insulin analogues.European journal of endocrinology · 2012
   Review
7. Using insulin in type 2 diabetes: in need of a renaissance?Journal of diabetes science and technology · 2011
   Review
8. The combinatorics of medications precludes evidence-based algorithms for therapy.Diabetologia · 2010
   Article
9. The American Association of Clinical Endocrinologists/American College of Endocrinology (AACE/ACE) algorithm for managing glycaemia in patients with type 2 diabetes mellitus: comparison with the ADA/EASD algorithm.Diabetologia · 2010
   Article
10. From authority recommendations to fact-sheets--a future for guidelines.Diabetologia · 2010
    Article
11. Should the algorithm for the treatment of type 2 diabetes be evidence-based?Diabetologia · 2010
    Article

Corrections and comments

• Commented on by
  The American Association of Clinical Endocrinologists/American College of Endocrinology (AACE/ACE) algorithm for managing glycaemia in patients with type 2 diabetes mellitus: comparison with the ADA/EASD algorithm.2010
• Commented on by
  The combinatorics of medications precludes evidence-based algorithms for therapy.2010
• Comment on
  Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis.2010
• Erratum issued

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as